138 related articles for article (PubMed ID: 32378551)
1. Soy β-Conglycinin Peptide Attenuates Obesity and Lipid Abnormalities in Obese Model OLETF Rats.
Wanezaki S; Saito S; Inoue N; Tachibana N; Shirouchi B; Sato M; Yanagita T; Nagao K
J Oleo Sci; 2020; 69(5):495-502. PubMed ID: 32378551
[TBL] [Abstract][Full Text] [Related]
2. Soy β-conglycinin improves obesity-induced metabolic abnormalities in a rat model of nonalcoholic fatty liver disease.
Wanezaki S; Tachibana N; Nagata M; Saito S; Nagao K; Yanagita T; Kohno M
Obes Res Clin Pract; 2015; 9(2):168-74. PubMed ID: 25890430
[TBL] [Abstract][Full Text] [Related]
3. Dietary β-Conglycinin Modulates Insulin Sensitivity, Body Fat Mass, and Lipid Metabolism in Obese Otsuka Long-Evans Tokushima Fatty (OLETF) Rats.
Kawabeta K; Hase-Tamaru S; Yuasa M; Suruga K; Sugano M; Koba K
J Oleo Sci; 2019 Apr; 68(4):339-350. PubMed ID: 30867392
[TBL] [Abstract][Full Text] [Related]
4. Soy β-conglycinin improves glucose uptake in skeletal muscle and ameliorates hepatic insulin resistance in Goto-Kakizaki rats.
Tachibana N; Yamashita Y; Nagata M; Wanezaki S; Ashida H; Horio F; Kohno M
Nutr Res; 2014 Feb; 34(2):160-7. PubMed ID: 24461318
[TBL] [Abstract][Full Text] [Related]
5. Serum lipid-improving effect of soyabean β-conglycinin in hyperlipidaemic menopausal women.
Ma D; Taku K; Zhang Y; Jia M; Wang Y; Wang P
Br J Nutr; 2013 Nov; 110(9):1680-4. PubMed ID: 23561330
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of β-conglycinin on renal function and nephrin expression in early streptozotocin-induced diabetic nephropathy rats.
Yang HY; Wu LY; Yeh WJ; Chen JR
Br J Nutr; 2014 Jan; 111(1):78-85. PubMed ID: 23803175
[TBL] [Abstract][Full Text] [Related]
7. Soybean beta-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of beta-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption.
Moriyama T; Kishimoto K; Nagai K; Urade R; Ogawa T; Utsumi S; Maruyama N; Maebuchi M
Biosci Biotechnol Biochem; 2004 Feb; 68(2):352-9. PubMed ID: 14981298
[TBL] [Abstract][Full Text] [Related]
8. β-conglycinin combined with fenofibrate or rosuvastatin have exerted distinct hypocholesterolemic effects in rats.
Ferreira ES; Silva MA; Demonte A; Neves VA
Lipids Health Dis; 2012 Jan; 11():11. PubMed ID: 22243700
[TBL] [Abstract][Full Text] [Related]
9. Structure-function properties of hypolipidemic peptides.
Nagaoka S
J Food Biochem; 2019 Jan; 43(1):e12539. PubMed ID: 31353491
[TBL] [Abstract][Full Text] [Related]
10. The α' subunit of β-conglycinin and various glycinin subunits of soy are not required to modulate hepatic lipid metabolism in rats.
Chatterjee C; Liu J; Wood C; Gagnon C; Cober ER; Frégeau-Reid JA; Gleddie S; Xiao CW
Eur J Nutr; 2018 Apr; 57(3):1157-1168. PubMed ID: 28324208
[TBL] [Abstract][Full Text] [Related]
11. Soya protein β-conglycinin ameliorates fatty liver and obesity in diet-induced obese mice through the down-regulation of PPARγ.
Li D; Ikaga R; Yamazaki T
Br J Nutr; 2018 Jun; 119(11):1220-1232. PubMed ID: 29770757
[TBL] [Abstract][Full Text] [Related]
12. Soy β-conglycinin retards progression of diabetic nephropathy via modulating the insulin sensitivity and angiotensin-converting enzyme activity in rats fed with high salt diet.
Yeh WJ; Yang HY; Chen JR
Food Funct; 2014 Nov; 5(11):2898-904. PubMed ID: 25205218
[TBL] [Abstract][Full Text] [Related]
13. Protective and reparative effects of peptides from soybean β-conglycinin on mice intestinal mucosa injury.
Ren J; Yang B; Lv Y; Guo S
Int J Food Sci Nutr; 2014 May; 65(3):345-50. PubMed ID: 24224901
[TBL] [Abstract][Full Text] [Related]
14. Soybean β-conglycinin improves carbohydrate and lipid metabolism in Wistar rats.
Inoue N; Fujiwara Y; Kato M; Funayama A; Ogawa N; Tachibana N; Kohno M; Ikeda I
Biosci Biotechnol Biochem; 2015; 79(9):1528-34. PubMed ID: 25913002
[TBL] [Abstract][Full Text] [Related]
15. Beta-conglycinin embeds active peptides that inhibit lipid accumulation in 3T3-L1 adipocytes in vitro.
Martinez-Villaluenga C; Bringe NA; Berhow MA; Gonzalez de Mejia E
J Agric Food Chem; 2008 Nov; 56(22):10533-43. PubMed ID: 18947234
[TBL] [Abstract][Full Text] [Related]
16. β-Conglycinin enhances autophagy in porcine enterocytes.
Yi D; Hou Y; Mei H; Wang L; Hu CA; Wu G
Amino Acids; 2017 Jan; 49(1):203-207. PubMed ID: 27761755
[TBL] [Abstract][Full Text] [Related]
17. Dietary soy beta-conglycinin (7S globulin) inhibits atherosclerosis in mice.
Adams MR; Golden DL; Franke AA; Potter SM; Smith HS; Anthony MS
J Nutr; 2004 Mar; 134(3):511-6. PubMed ID: 14988439
[TBL] [Abstract][Full Text] [Related]
18. Dietary β-conglycinin prevents fatty liver induced by a high-fat diet by a decrease in peroxisome proliferator-activated receptor γ2 protein.
Yamazaki T; Kishimoto K; Miura S; Ezaki O
J Nutr Biochem; 2012 Feb; 23(2):123-32. PubMed ID: 21447441
[TBL] [Abstract][Full Text] [Related]
19. Beta-conglycinin lowers very-low-density lipoprotein-triglyceride levels by increasing adiponectin and insulin sensitivity in rats.
Tachibana N; Iwaoka Y; Hirotsuka M; Horio F; Kohno M
Biosci Biotechnol Biochem; 2010; 74(6):1250-5. PubMed ID: 20530915
[TBL] [Abstract][Full Text] [Related]
20. Protein hydrolysates from beta-conglycinin enriched soybean genotypes inhibit lipid accumulation and inflammation in vitro.
Martinez-Villaluenga C; Dia VP; Berhow M; Bringe NA; Gonzalez de Mejia E
Mol Nutr Food Res; 2009 Aug; 53(8):1007-18. PubMed ID: 19603404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
